Winter, H., Baldassano, R. N., Pfeffkorn, M. D., Wali, P., Verstraete, S. G., Picoraro, J. A., Washek, M. A., Kumar, N., Mortan, W., Havard- Jr, M., Blystone, L., Trombler, B., Pursley, C., Lin, X., Dillon, S. T., Gu, X., Otu, H. H., Ngo, L., & Libermann, T. A. (2024). P192 Personalizing treatment for predicting response to infliximab in children with Crohn’s disease using proteomic biomarkers. Journal of Crohn’s and Colitis, 18(Supplement_1), i506–i506. https://doi.org/10.1093/ecco-jcc/jjad212.0322
Subjects:
Genetics and Treatment of Inflammatory Bowel Disease
(OpenAlex Topic)
Immunogenicity of Biosimilar Therapeutics in Drug Development
(OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1093/ecco-jcc/jjad212.0322
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: